| Citation: |
GU Jianguo, NI Jie, SI Guojun. Correlation of serum B-cell activating factor level with cardiovascular events in patients with ST segment elevation myocardial infarction[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 52-56. DOI: 10.7619/jcmp.20233732
|
To evaluate the value of serum B-cell activating factor (BAFF) level in predicting cardiovascular events in patients with ST segment elevation myocardial infarction (STEMI).
A total of 166 patients with coronary angiography for STEMI in the Nantong Third Hospital Affiliated to Nantong University from January 2020 to June 2022 were selected as research objects, and general materials, medical history, echocardiography and laboratory data were collected. Patients were followed up for 12 months to record the incidence condition of major adverse cardiac events (MACE). The predictive value of serum BAFF level for MACE was evaluated by Cox proportional hazard model; the receiver operating characteristic (ROC) curve of serum BAFF level for prediction of MACE was drawn, and the area under curve (AUC) was calculated. The optimal cut-off value for serum BAFF level was determined by the ROC curve, the patients were grouped based on this optimal cut-off, and the Log-rank test was used to draw the Kaplan-Meier curve for analyzing the incidence of MACE.
Among the 166 patients, 26 cases had MACE within 12 months of follow-up, and the incidence rate of MACE was 15.7 %. In the MACE group, the age and levels of triglycerides, low-density lipoprotein, cardiac troponin Ⅰ, creatine kinase isoenzyme, and serum BAFF were significantly higher than those in the non-MACE group (P < 0.05). Cox proportional hazard model analysis revealed that there was a significant positive correlation between age and incidence of MACE (HR=1.267, 95 %CI, 1.126 to 1.426, P < 0.001) as well as a significant positive association between serum BAFF level and incidence of MACE (HR=1.020, 95 %CI, 1.003 to 1.038, P=0.024). The sensitivity of serum BAFF level in predicting MACE was 76.2 %, and the specificity was 82.9 %. ROC curve analysis identified the optimal cut-off value of serum BAFF was 1.07 ng/mL, patients were divided into a group with serum BAFF>1.07 ng/mL and another with serum BAFF ≤ 1.07 ng/mL, and the cumulative survival rate in the group with serum BAFF ≤ 1.07 ng/mL was significantly higher than that in the group with serum BAFF>1.07 ng/mL (P < 0.001).
The increase of serum BAFF level is significantly positively correlated with the increased incidence of MACE in STEMI patients, and serum BAFF level can be used as a predictor of cardiovascular events in STEMI patients.
| [1] |
GONG F F, VAITENAS I, MALAISRIE S C, et al. Mechanical complications of acute myocardial infarction: a review[J]. JAMA Cardiol, 2021, 6(3): 341-349. doi: 10.1001/jamacardio.2020.3690
|
| [2] |
SUN Y Y, PINTO C, CAMUS S, et al. Splenic marginal zone B lymphocytes regulate cardiac remodeling after acute myocardial infarction in mice[J]. J Am Coll Cardiol, 2022, 79(7): 632-647. doi: 10.1016/j.jacc.2021.11.051
|
| [3] |
CASAROTTI A C A, TEIXEIRA D, LONGO-MAUGERI I M, et al. Role of B lymphocytes in the infarcted mass in patients with acute myocardial infarction[J]. Biosci Rep, 2021, 41(2): BSR20203413. doi: 10.1042/BSR20203413
|
| [4] |
KYAW T, TOH B H, BOBIK A. Evolving BAFF targeted therapies for preventing acute myocardial infarctions and ischemic strokes[J]. Expert Opin Ther Targets, 2020, 24(1): 7-12. doi: 10.1080/14728222.2020.1708325
|
| [5] |
MÖCKEL T, BASTA F, WEINMANN-MENKE J, et al. B cell activating factor (BAFF): structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE)[J]. Autoimmun Rev, 2021, 20(2): 102736. doi: 10.1016/j.autrev.2020.102736
|
| [6] |
中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南(2019)[J]. 中华心血管病杂志, 2019, 47(10): 766-783 https://www.cnki.com.cn/Article/CJFDTOTAL-ZJXB201709002.htm
|
| [7] |
SMULSKI C R, EIBEL H. BAFF and BAFF-receptor in B cell selection and survival[J]. Front Immunol, 2018, 9: 2285. doi: 10.3389/fimmu.2018.02285
|
| [8] |
SCHWEIGHOFFER E, TYBULEWICZ V L. BAFF signaling in health and disease[J]. Curr Opin Immunol, 2021, 71: 124-131. doi: 10.1016/j.coi.2021.06.014
|
| [9] |
LI K, YU W, CAO R J, et al. Microglia-mediated BAFF-BAFFR ligation promotes neuronal survival in brain ischemia injury[J]. Neuroscience, 2017, 363: 87-96. doi: 10.1016/j.neuroscience.2017.09.007
|
| [10] |
PATTARABANJIRD T, LI C, MCNAMARA C. B cells in atherosclerosis: mechanisms and potential clinical applications[J]. JACC Basic Transl Sci, 2021, 6(6): 546-563. doi: 10.1016/j.jacbts.2021.01.006
|
| [11] |
SAIDOUNE F, EVEN G, LAMRI Y, et al. Effects of BAFF neutralization on atherosclerosis associated with systemic lupus erythematosus[J]. Arthritis Rheumatol, 2021, 73(2): 255-264. doi: 10.1002/art.41485
|
| [12] |
THEODOROU E, NEZOS A, ANTYPA E, et al. B-cell activating factor and related genetic variants in lupus related atherosclerosis[J]. J Autoimmun, 2018, 92: 87-92. doi: 10.1016/j.jaut.2018.05.002
|
| [13] |
TAY C, KANELLAKIS P, HOSSEINI H, et al. B cell and CD4 T cell interactions promote development of atherosclerosis[J]. Front Immunol, 2019, 10: 3046.
|
| [14] |
POZNYAK A V, BEZSONOV E E, POPKOVA T V, et al. Immunity in atherosclerosis: focusing on T and B cells[J]. Int J Mol Sci, 2021, 22(16): 8379. doi: 10.3390/ijms22168379
|
| [15] |
顾园竹, 张文静, 查才军, 等. B细胞激活因子(BAFF)与抗磷脂综合征血栓形成关系的研究进展[J]. 现代检验医学杂志, 2021, 36(2): 161-164. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYN202102038.htm
|
| [16] |
KYAW T, CUI P, TAY C, et al. BAFF receptor MAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE (-/-) mice[J]. PLoS One, 2013, 8(4): e60430. doi: 10.1371/journal.pone.0060430
|
| [17] |
NATORSKA J, MAREK G, SADOWSKI J, et al. Presence of B cells within aortic valves in patients with aortic stenosis: relation to severity of the disease[J]. J Cardiol, 2016, 67(1): 80-85. doi: 10.1016/j.jjcc.2015.05.002
|
| [18] |
BRYL-GÓRECKA P, JAMES K, TORNGREN K, et al. Microvesicles in plasma reflect coronary flow reserve in patients with cardiovascular disease[J]. Am J Physiol Heart Circ Physiol, 2021, 320(5): H2147-H2160. doi: 10.1152/ajpheart.00869.2020
|
| [19] |
ZHANG X Y, WANG S J, LIU J X, et al. D-dimer and the incidence of heart failure and mortality after acute myocardial infarction[J]. Heart, 2021, 107(3): 237-244. doi: 10.1136/heartjnl-2020-316880
|
| [20] |
黄伟涛. 不同血清学指标联合诊断在急性心肌梗死患者PCI后心功能中的预测价值[J]. 检验医学与临床, 2023, 20(17): 2505-2509. https://www.cnki.com.cn/Article/CJFDTOTAL-JYYL202317011.htm
|
| [21] |
陈磊, 刘新灿, 王炜, 等. 急性心肌梗死患者血清N末端脑钠肽前体、载脂蛋白E、载脂蛋白A1、载脂蛋白B水平与冠状动脉病变的关系探究[J]. 中国临床医生杂志, 2022, 50(5): 550-554. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLYS202205014.htm
|
| [22] |
YAN X X, ANZAI A, KATSUMATA Y, et al. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction[J]. J Mol Cell Cardiol, 2013, 62: 24-35. doi: 10.1016/j.yjmcc.2013.04.023
|
| [23] |
ADAMO L, STALOCH L J, ROCHA-RESENDE C, et al. Modulation of subsets of cardiac B lymphocytes improves cardiac function after acute injury[J]. JCI Insight, 2018, 3(11): e120137. doi: 10.1172/jci.insight.120137
|
| [24] |
MO F R, LUO Y, YAN Y L, et al. Are activated B cells involved in the process of myocardial fibrosis after acute myocardial infarction?An in vivo experiment[J]. BMC Cardiovasc Disord, 2021, 21(1): 5. doi: 10.1186/s12872-020-01775-9
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: